Biotech companies disclose Nasdaq inducement grants for new employees
Dianthus, Taysha and aTyr disclosed inducement equity grants for newly hired employees under Nasdaq Listing Rule 5635(c)(4), detailing share awards, vesting schedules and exercise prices.
Dianthus Therapeutics, Inc., Taysha Gene Therapies, Inc. and aTyr Pharma, Inc. announced inducement equity grants to newly hired employees under Nasdaq Listing Rule 5635(c)(4). The grants were approved by compensation committees and were described as material inducements to acceptance of employment. Dianthus and Taysha announced the awards on May 1, 2026, while aTyr announced its grants on Feb. 20, 2026.
Dianthus said it granted equity awards on May 1, 2026, to six newly-hired, non-executive employees. The inducement grants consist of non-qualified stock options to purchase an aggregate of 135,000 shares of the company's common stock with a 10-year term and an exercise price of $87.42 per share. The options vest as to 25% on the first anniversary of the vesting commencement date and in equal monthly installments for the following 36 months.
Taysha said that, on May 1, 2026, the Compensation Committee of its Board of Directors granted five new employees, in the aggregate, restricted stock units representing 188,000 shares of the company's common stock in connection with their employment. The RSUs were granted under the 2023 Inducement Plan as an inducement material to the individuals entering employment with Taysha in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest in four equal annual installments beginning on the first anniversary of the award's vesting commencement date, subject to continued service with the company through each vesting date.
aTyr said the Compensation Committee of its Board of Directors granted two employees nonstatutory stock options to purchase an aggregate of 12,200 shares of aTyr's common stock, each with an exercise price of $0.98 per share, equal to the closing price of aTyr's common stock on the Nasdaq Capital Market on Feb. 17, 2026, the effective date of the grants. The stock awards were granted as an inducement material to the new employees entering into employment with aTyr in accordance with Nasdaq Listing Rule 5635(c)(4) and were made pursuant to the 2022 Inducement Plan. Each option vests over a period of four years, with 25% of the shares vesting on the one-year anniversary of the applicable vesting commencement date and the remaining 75% vesting in equal monthly installments over three years, subject to continued employment through each vesting date.